삼성서울병원

Ko En

Pathology Choi, Yoon La M.D

TITLE
Associate Professor of Pathology, Sungkyunkwan University School of Medicine, Samsung Medical center
Treament Schedule 06 月
DATE
TUE
01
WEB
02
THU
03
FRI
04
SAT
05
SUN
06
MON
07
TUE
08
WEB
09
THU
10
FRI
11
SAT
12
SUN
13
MON
14
TUE
15
WEB
16
THU
17
FRI
18
SAT
19
SUN
20
MON
21
TUE
22
WEB
23
THU
24
FRI
25
SAT
26
SUN
27
MON
28
TUE
29
WEB
30
AM
PM
Treament Schedule 07 月
DATE
THU
01
FRI
02
SAT
03
SUN
04
MON
05
TUE
06
WEB
07
THU
08
FRI
09
SAT
10
SUN
11
MON
12
TUE
13
WEB
14
THU
15
FRI
16
SAT
17
SUN
18
MON
19
TUE
20
WEB
21
THU
22
FRI
23
SAT
24
SUN
25
MON
26
TUE
27
WEB
28
THU
29
FRI
30
SAT
31
AM
PM

Medical School

Seoul National University College of Medicine

Specialty Training

Fellowship   Seoul National University Hospital
Samsung Medical Center
Residency   Samsung Medical Center
Internship   Seoul National University Hospital

Other Education

Stanford University, Department of Pathology, Visiting Instructor

Clinical & Research Interests

Molecular Pathology, Bone & soft tissue Pathology

Participation in Academic Societies
and Research

· A member of Korean Pathology Society
· A member of Korean Breast Cancer Society
· A member of United States and Canadian Academy of Pathology
· A member of American Association for Cancer Research

Selected Publications

  • NAT COMMUN 2020 10.1038/s41467-020-19933-0 Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome Park1, YH; Lal, S; Lee, JE; Choi, YL; Wen, J; Ram, S; Ding, Y; Lee, SH; Powell, E; Lee, SK; Yu, JH; Ching, KA; Nam, JY; Kim, SW; Nam, SJ; Kim, JY; Cho, SY; Park, S; Kim, J; Hwang, S; Kim, YJ; Bonato, V; Fernandez, D; Deng, S; Wang, S; Shin, H; Kang, ES; Park, WY; Rejto, PA; Bienkowska, J; Kan, Z
    View PubMed
  • J THORAC ONCOL 2020 10.1016/j.jtho.2020.06.018 Osimertinib Improves Overall Survival in Patients With EGFR-Mutated NSCLC With Leptomeningeal Metastases Regardless of T790M Mutational Status Lee1, J; Choi, YL; Han, J; Park, S; Jung, HA; Su, JM; Lee, SH; Ahn, JS; Park, K; Ahn, MJ
    View PubMed
  • THORAC CANCER 2020 10.1111/1759-7714.13648 Clinicopathological characteristics of primary lung nuclear protein in testis carcinoma A single-institute experience of 10 cases Cho1, YA; Choi, YL; Hwang, I; Lee, K; Cho, JH; Han, J
    View PubMed
  • CANCER IMMUNOL IMMUN 2020 10.1007/s00262-020-02766-7 Nivolumab for esophageal squamous cell carcinoma and the predictive role of PD-L1 or CD8 expression in its therapeutic effect Lee1, J; Kim, B; Jung, HA; Choi, YL; Sun, JM
    View PubMed
  • J THORAC DIS 2020 10.21037/jtd-20-1716 Clinicoradiopathological features and prognosis according to genomic alterations in patients with resected lung adenocarcinoma Choi1, Y; Kim, KH; Jeong, BH; Lee, KJ; Kim, H; Kwon, OJ; Kim, J; Choi, YL; Lee, HY; Um, SW
    View PubMed